Related Experiment Video
Updated: Jul 8, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Postoperative cardiac biomarker release is not associated with myocardial mass in computer tomography scans
Leo Pölzl1, Philipp Sterzinger2, Ronja Lohmann1
1Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Insights
Myocardial mass does not influence postoperative cardiac biomarker release after heart surgery. Further research is needed to identify factors affecting biomarker levels following aortic valve replacement or bypass procedures.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomarker Research
Background:
- Myocardial hypertrophy is linked to elevated cardiac biomarkers in various conditions.
- The impact of cardiac mass on postoperative biomarker release after cardiac surgery is not well understood.
Purpose of the Study:
- To investigate the correlation between myocardial mass and the release of high-sensitivity cardiac Troponin T (hs-cTnT) and creatine kinase-myocardial band (CK-MB).
- To examine this relationship following isolated aortic valve replacement (AVR) or bypass surgery.
Main Methods:
- Retrospective analysis of 636 patients undergoing AVR or bypass surgery.
- Myocardial mass assessed via preoperative CT scans; cardiac biomarkers measured serially post-surgery.
- Statistical analysis included correlation and multivariate regression models.
Main Results:
- Preoperative biomarker levels were higher in patients with greater myocardial mass index, particularly those undergoing AVR or bypass surgery.
- No significant differences in postoperative hs-cTnT or CK-MB release were observed between patients with varying heart sizes.
- No statistical correlation found between myocardial mass index and postoperative biomarker release.
Conclusions:
- Postoperative release of cardiac biomarkers is independent of myocardial mass.
- Future studies should explore other patient factors influencing postoperative biomarker levels.
Objectives:
Myocardial hypertrophy results in increased levels of cardiac biomarkers in healthy individuals and in patients suffering from acute myocardial infarction. The influence of cardiac mass on postoperative cardiac biomarkers release remains unclear. This study investigated the correlation between myocardial mass and the release of high-sensitivity cardiac Troponin T (hs-cTnT) and creatine kinase-myocardial band (CK-MB) after isolated aortic valve replacement (AVR) or bypass surgery.
Methods:
Myocardial mass of a consecutive retrospective series of patients was measured automatically using preoperative computer tomography scans (636 patients, AVR = 251; bypass surgery = 385). Levels of cardiac biomarkers were measured before and serially after surgery. Spearman and Pearson correlation and a multivariate regression model was performed to measure the degree of association between myocardial mass and the release of hs-cTnT and CK-MB.
Results:
Patients were divided into 3 tertiles according to their myocardial mass index. Higher biomarker levels were measured preoperatively in the upper tertile of patients undergoing AVR (P = 0.004) or bypass surgery (P < 0.001). Patients with different heart sizes showed no differences in postoperative biomarker release neither after AVR nor bypass surgery. No statistical significant correlation was observed between myocardial mass index and postoperative release of hs-cTnT or CK-MB in any subgroup (ρ maximum 0.106).
Conclusions:
Postoperative biomarker release is not correlated with myocardial mass. Patient factors leading to increased postoperative biomarker levels need to be elucidated in future studies.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...